- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 255/24 - Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
Patent holdings for IPC class C07C 255/24
Total number of patents in this class: 79
10-year publication summary
1
|
9
|
10
|
3
|
7
|
0
|
5
|
7
|
6
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Acuitas Therapeutics Inc. | 114 |
10 |
Modernatx, Inc. | 1263 |
10 |
BASF SE | 20915 |
7 |
Ascend Performance Materials Operations LLC | 272 |
3 |
Cansino Biologics Inc. | 75 |
3 |
DuPont Electronic Materials International, LLC | 429 |
3 |
Rhodia Operations | 1586 |
2 |
Vivace Therapeutics, Inc. | 30 |
2 |
The Procter & Gamble Company | 22043 |
1 |
Bristol-myers Squibb Company | 4893 |
1 |
Hoffmann-La Roche Inc. | 3422 |
1 |
Pfizer Inc. | 3381 |
1 |
Merck Patent GmbH | 5823 |
1 |
BASF AG | 246 |
1 |
Dow Global Technologies LLC | 10332 |
1 |
Showa Denko K.K. | 2226 |
1 |
The Trustees of the University of Pennsylvania | 4323 |
1 |
Astellas Pharma Inc. | 1092 |
1 |
BioAmber S.A.S. | 20 |
1 |
Bose Institute | 4 |
1 |
Other owners | 27 |